COMMUNIQUÉS West-GlobeNewswire

Sanofi : Le CHMP recommande l'approbation de Praluent® (alirocumab) pour la réduction du risque cardiovasculaire chez les personnes atteintes de maladie cardiovasculaire athéroscléreuse établie
04/02/2019
Le CHMP recommande l'approbation de Praluent ® (alirocumab) pour la réduction du risque cardiovasculaire chez les personnes atteintes de maladie cardiovasculaire athéroscléreuse établie Paris et Tarrytown (New York) - [...]
argenx and Halozyme enter global collaboration and license agreement for ENHANZE® technology
04/02/2019
argenx gains access to ENHANZE® subcutaneous delivery technology for up to three targets, including exclusive rights to develop therapeutic products targeting human neonatal Fc receptor FcRn February 4, 2019 Breda, the [...]
CROSSJECT : Financement de 1,1 M€ accordé conjointement par Bpifrance et la région Bourgogne-Franche Comté
04/02/2019
Communiqué de Presse Financement de 1,1 M€ accordé conjointement par Bpifrance et la région Bourgogne-Franche Comté Dijon, le 4 février 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Nancy J. Sandy nommée directrice générale de Taconic Biosciences
01/02/2019
RENSSELAER, NY, 01 févr. 2019 (GLOBE NEWSWIRE) -- Le conseil d’administration de Taconic Biosciences a choisi Nancy J. Sandy pour succéder à M. Robert J. Rosenthal au poste de directeur général (DG). Mme Sandy est à la [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
BURLINGTON, Mass., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to 14 new employees for an aggregate of 51,000 shares of common stock. [...]
Evolus Receives FDA Approval for Jeuveau™ prabotulinumtoxinA-xvfs for Injection
01/02/2019
Jeuveau™ is the first aesthetic-only neurotoxin approved in the U.S. – launch planned Spring 2019 Global clinical program in 2,100 subjects, known as TRANSPARENCY, included two Phase III U.S. trials, the largest head-to [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
EMERYVILLE, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
BOTHELL, Wash., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/02/2019
BOSTON, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today announced that on [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/02/2019
SANTA BARBARA, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on January 31, 2019, the Compensation Committee of [...]
Tabula Rasa HealthCare’s Subsidiary Completes Implementation of Precision Dosing Software for One of the Nation’s Leading Healthcare Systems
01/02/2019
MOORESTOWN, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced its newly acquired [...]
Pixium Vision: Information on total number of voting rights and shares composing the share capital as at January 31st, 2019
01/02/2019
Information on total number of voting rights and shares composing the share capital as at January 31 st , 2019 Paris, February 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company [...]
Pixium Vision : Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2019
01/02/2019
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2019 Paris, le 1 er février 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique [...]
Nicox: Number of voting rights as of january 31, 2019
01/02/2019
Nicox SA Société anonyme with a registered capital of € 29,718,920 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On February 1, 2019, MONTHLY PUBLICATION OF THE [...]
Nicox : Nombre de droits de vote au 31 janvier 2019
01/02/2019
Nicox SA Société anonyme au capital de 29 718 920 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1er février 2019, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Title21 Health Solutions Is a ‘Great Place to Work’®
01/02/2019
Cellular Therapy and Enterprise Quality Management Software Company is Recognized as Having an Outstanding Culture by Great Place to Work® PLEASANTON, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Title21 Health Solutions [...]
BioAegis Therapeutics Announces Publication in “Clinical Infectious Diseases” Linking Depleted Plasma Gelsolin Concentrations at Admission to Severe Pneumonia Outcomes in CDC-Sponsored “Etiology of Pneumonia in the Community (EPIC)” Study
01/02/2019
MORRISTOWN, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced the publication of a paper in Clinical Infectious Disease—a journal of the Infectious Disease Society of America entitled, Low [...]
Active Biotech has received an indicative bid for the property in Lund - the Board is positive
01/02/2019
As previously reported, Active Biotech's property Forskaren 1 in Lund has been on sale for a period of time. Active Biotech has now received an indicative, non-binding bid for the property, amounting to SEK 275 million [...]
Typenex® Medical Awarded National MAGNET GROUP Contract
01/02/2019
Gives Members Access to Full Portfolio of Patient Identification Products CHICAGO, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Typenex Medical , an industry leader in Healthcare, announced it has been awarded the MAGNET GROUP GPO [...]

Pages